Should We Abandon the FISH Test?

European Urology

Volumn 51, Issue 6, 2007, Pages 1469-1471

  Nieder, Alan M ^a   Soloway, Mark S ^a   Herr, Harry W ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

BLADDER CANCER; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; EDITORIAL; FLUORESCENCE IN SITU HYBRIDIZATION; HEALTH CARE COST; HUMAN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

CHROMOSOMES, HUMAN, PAIR 17; CHROMOSOMES, HUMAN, PAIR 21; CHROMOSOMES, HUMAN, PAIR 3; CHROMOSOMES, HUMAN, PAIR 7; CYTOLOGICAL TECHNIQUES; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; SENSITIVITY AND SPECIFICITY; UNITED STATES; URINARY BLADDER NEOPLASMS;

EID: 34247355580     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2007.01.044     Document Type: Editorial

References (14)

1. Jemal A., Murray T., Ward E., et al. Cancer statistics, 2005. CA Cancer J Clin 55 (2005) 10-30
2. Grossfeld G.D., Litwin M.S., Wolf Jr. J.S., et al. Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy-part II: patient evaluation, cytology, voided markers, imaging, cystoscopy, nephrology evaluation, and follow-up. Urology 57 (2001) 604-610
3. Lokeshwar V.B., Habuchi T., Grossman H.B., et al. Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers. Urology 66 (2005) 35-63
4. Murphy W.M., Crabtree W.N., Jukkola A.F., and Soloway M.S. The diagnostic value of urine versus bladder washing in patients with bladder cancer. J Urol 126 (1981) 320-322
5. Matzkin H., Moinuddin S.M., and Soloway M.S. Value of urine cytology versus bladder washing in bladder cancer. Urology 39 (1992) 201-203
6. Sarosdy M.F., Schellhammer P., Bokinsky G., et al. Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer. J Urol 168 (2002) 1950-1954
7. Skacel M., Fahmy M., Brainard J.A., et al. Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology. J Urol 169 (2003) 2101-2105
8. Halling K.C., King W., Sokolova I.A., et al. A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma. J Urol 164 (2000) 1768-1775
9. van Rhijn B.W., van der Poel H.G., and van der Kwast T.H. Urine markers for bladder cancer surveillance: a systematic review. Eur Urol 47 (2005) 736-748
10. Nieder A.M., Meinbach D.S., Kim S.S., and Soloway M.S. Transurethral bladder tumor resection: intraoperative and postoperative complications in a residency setting. J Urol 174 (2005) 2307-2309
11. Sangar V.K., Ragavan N., Matanhelia S.S., Watson M.W., and Blades R.A. The economic consequences of prostate and bladder cancer in the UK. BJU Int 95 (2005) 59-63
12. Botteman M.F., Pashos C.L., Redaelli A., Laskin B., and Hauser R. The health economics of bladder cancer: a comprehensive review of the published literature. Pharmacoeconomics 21 (2003) 1315-1330
13. Murakami S., Igarashi T., Hara S., and Shimazaki J. Strategies for asymptomatic microscopic hematuria: a prospective study of 1,034 patients. J Urol 144 (1990) 99-101
14. Ritchie C.D., Bevan E.A., and Collier S.J. Importance of occult haematuria found at screening. Br Med J (Clin Res Ed) 292 (1986) 681-683